Candidate gene sequencing of SLC11A2 and TMPRSS6 in a family with severe anaemia: Common SNPs, rare haplotypes, no causative mutation

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Kloss Brandstätter, Anita ^a   Erhart, Gertraud ^a   Lamina, Claudia ^a   Meister, Bernhard ^a   Haun, Margot ^a   Coassin, Stefan ^a   Seifert, Markus ^a   Klein Franke, Andreas ^a   Paulweber, Bernhard ^b   Kedenko, Lyudmyla ^b   Kollerits, Barbara ^a   Swinkels, Dorine W ^c   Vermeulen, Sita H ^c   Galesloot, Tessel E ^c   Kronenberg, Florian ^a   Weiss, Günter ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON; CATION TRANSPORT PROTEIN; MEMBRANE PROTEIN; SERINE PROTEINASE; SOLUTE CARRIER FAMILY 11 (PROTON COUPLED DIVALENT METAL ION TRANSPORTERS), MEMBER 2; SOLUTE CARRIER FAMILY 11- (PROTON-COUPLED DIVALENT METAL ION TRANSPORTERS), MEMBER 2; TMPRSS6 PROTEIN, HUMAN;

ARTICLE; CHILD; DISEASE SEVERITY; EXON; FAMILY STUDY; FEMALE; FERRITIN BLOOD LEVEL; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; HUMAN CELL; INTRON; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; PATIENT COMPLIANCE; POPULATION GENETICS; POPULATION RESEARCH; SINGLE NUCLEOTIDE POLYMORPHISM; SLC11A2 GENE; TMPRSS6 GENE; ADULT; BLOOD; CASE REPORT; DIET SUPPLEMENTATION; GENETICS; INFANT; MUTATION; PEDIGREE; PRESCHOOL CHILD; SERBIA;

ADULT; ANEMIA, IRON-DEFICIENCY; CATION TRANSPORT PROTEINS; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; FEMALE; FERRITINS; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HUMANS; INFANT; IRON; MALE; MEMBRANE PROTEINS; MUTATION; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; SERBIA; SERINE ENDOPEPTIDASES;

EID: 84859599042     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035015     Document Type: Article

References (47)

1. Anderson GJ, Frazer DM, McLaren GD, (2009) Iron absorption and metabolism. Curr Opin Gastroenterol 25: 129-135.
2. Finberg KE, (2009) Iron-refractory iron deficiency anemia. Semin Hematol 46: 378-386.
3. Camaschella C, Poggiali E, (2011) Inherited disorders of iron metabolism. Curr Opin Pediatr 23: 14-20.
4. Ludwiczek S, Theurl I, Muckenthaler MU, Jakab M, Mair SM, et al. (2007) Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1. Nat Med 13: 448-454.
5. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, et al. (1997) Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388: 482-488.
6. Fleming MD, Trenor CC, Su MA, Foernzler D, Beier DR, et al. (1997) Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 16: 383-386.
7. Chew KC, Ang ET, Tai YK, Tsang F, Lo SQ, et al. (2011) Enhanced autophagy from chronic toxicity of iron and mutant A53T alpha-synuclein: implications for neuronal cell death in Parkinson disease. J Biol Chem 286: 33380-33389.
8. Mims MP, Guan Y, Pospisilova D, Priwitzerova M, Indrak K, et al. (2005) Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload. Blood 105: 1337-1342.
9. Iolascon A, D'Apolito M, Servedio V, Cimmino F, Piga A, et al. (2006) Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2). Blood 107: 349-354.
10. Beaumont C, Delaunay J, Hetet G, Grandchamp B, de MM, et al. (2006) Two new human DMT1 gene mutations in a patient with microcytic anemia, low ferritinemia, and liver iron overload. Blood 107: 4168-4170.
11. Blanco E, Kannengiesser C, Grandchamp B, Tasso M, Beaumont C, (2009) Not all DMT1 mutations lead to iron overload. Blood Cells Mol Dis 43: 199-201.
12. Iolascon A, Camaschella C, Pospisilova D, Piscopo C, Tchernia G, et al. (2008) Natural history of recessive inheritance of DMT1 mutations. J Pediatr 152: 136-139.
13. Finberg KE, Heeney MM, Campagna DR, Aydinok Y, Pearson HA, et al. (2008) Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet 40: 569-571.
14. Ramsay AJ, Quesada V, Sanchez M, Garabaya C, Sarda MP, et al. (2009) Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms. Hum Mol Genet 18: 3673-3683.
15. Altamura S, D'Alessio F, Selle B, Muckenthaler MU, (2010) A novel TMPRSS6 mutation that prevents protease auto-activation causes IRIDA. Biochem J 431: 363-371.
16. De Falco L, Totaro F, Nai A, Pagani A, Girelli D, et al. (2010) Novel TMPRSS6 mutations associated with iron-refractory iron deficiency anemia (IRIDA). Hum Mutat 31: E1390-E1405.
17. Ramsay AJ, Hooper JD, Folgueras AR, Velasco G, Lopez-Otin C, (2009) Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis. Haematologica 94: 840-849.
18. Hentze MW, Muckenthaler MU, Galy B, Camaschella C, (2010) Two to tango: regulation of Mammalian iron metabolism. Cell 142: 24-38.
19. Silvestri L, Pagani A, Nai A, De Domenico I, Kaplan J, et al. (2008) The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab 8: 502-511.
20. Ganz T, Nemeth E, (2011) Hepcidin and disorders of iron metabolism. Annu Rev Med 62: 347-360.
21. Knutson MD, Oukka M, Koss LM, Aydemir F, Wessling-Resnick M, (2005) Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc Natl Acad Sci U S A 102: 1324-1328.
22. Theurl I, Theurl M, Seifert M, Mair S, Nairz M, et al. (2008) Autocrine formation of hepcidin induces iron retention in human monocytes. Blood 111: 2392-2399.
23. Benyamin B, Ferreira MA, Willemsen G, Gordon S, Middelberg RP, et al. (2009) Common variants in TMPRSS6 are associated with iron status and erythrocyte volume. Nat Genet 41: 1173-1175.
24. Tanaka T, Roy CN, Yao W, Matteini A, Semba RD, et al. (2010) A genome-wide association analysis of serum iron concentrations. Blood 115: 94-96.
25. Pichler I, Minelli C, Sanna S, Tanaka T, Schwienbacher C, et al. (2011) Identification of a common variant in the TFR2 gene implicated in the physiological regulation of serum iron levels. Hum Mol Genet 20: 1232-1240.
26. Chambers JC, Zhang W, Li Y, Sehmi J, Wass MN, et al. (2009) Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels. Nat Genet 41: 1170-1172.
27. Ganesh SK, Zakai NA, van Rooij FJ, Soranzo N, Smith AV, et al. (2009) Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet 41: 1191-1198.
28. Berglund S, Westrup B, Domellof M, (2010) Iron supplements reduce the risk of iron deficiency anemia in marginally low birth weight infants. Pediatrics 126: e874-e883.
29. Kroot JJ, Laarakkers CM, Geurts-Moespot AJ, Grebenchtchikov N, Pickkers P, et al. (2010) Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem 56: 1570-1579.
30. Swinkels DW, Girelli D, Laarakkers C, Kroot J, Campostrini N, et al. (2008) Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS ONE 3: e2706.
31. Heid IM, Wagner SA, Gohlke H, Iglseder B, Mueller JC, et al. (2006) Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 55: 375-384.
32. Brandstätter A, Lamina C, Kiechl S, Hunt SC, Coassin S, et al. (2010) Sex and age interaction with genetic association of atherogenic uric acid concentrations. Atherosclerosis 210: 474-478.
33. Hoogendoorn EH, Hermus AR, de VF, Ross HA, Verbeek AL, et al. (2006) Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem 52: 104-111.
34. Li J, Ji L, (2005) Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95: 221-227.
35. Coassin S, Brandstätter A, Kronenberg F, (2010) Lost in the space of bioinformatic tools: A constantly updated survival guide for genetic epidemiology. The GenEpi Toolbox. Atherosclerosis 209: 321-335.
36. Delbini P, Vaja V, Graziadei G, Duca L, Nava I, et al. (2010) Genetic variability of TMPRSS6 and its association with iron deficiency anaemia. Br J Haematol 151: 281-284.
37. Guillem F, Lawson S, Kannengiesser C, Westerman M, Beaumont C, et al. (2008) Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency. Blood 112: 2089-2091.
38. Soranzo N, Sanna S, Wheeler E, Gieger C, Radke D, et al. (2010) Common variants at 10 genomic loci influence hemoglobin A(C) levels via glycemic and nonglycemic pathways. Diabetes 59: 3229-3239.
39. Wetzels JF, Kiemeney LA, Swinkels DW, Willems HL, den HM, (2007) Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int 72: 632-637.
40. Lim CY, Santoso B, Boulay T, Dong E, Ohler U, et al. (2004) The MTE, a new core promoter element for transcription by RNA polymerase II. Genes Dev 18: 1606-1617.
41. Yang JS, Phillips MD, Betel D, Mu P, Ventura A, et al. (2011) Widespread regulatory activity of vertebrate microRNA* species. RNA 17: 312-326.
42. Abkevich V, Zharkikh A, Deffenbaugh AM, Frank D, Chen Y, et al. (2004) Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation. J Med Genet 41: 492-507.
43. Wang GS, Cooper TA, (2007) Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet 8: 749-761.
44. Houdayer C, Dehainault C, Mattler C, Michaux D, Caux-Moncoutier V, et al. (2008) Evaluation of in silico splice tools for decision-making in molecular diagnosis. Hum Mutat 29: 975-982.
45. Melis MA, Cau M, Congiu R, Sole G, Barella S, et al. (2008) A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron. Haematologica 93: 1473-1479.
46. Song YS, Wang F, Slatkin M, (2010) General epistatic models of the risk of complex diseases. Genetics 186: 1467-1473.
47. Brasse-Lagnel C, Karim Z, Letteron P, Bekri S, Bado A, et al. (2011) Intestinal DMT1 cotransporter is down-regulated by hepcidin via proteasome internalization and degradation. Gastroenterology 140: 1261-1271.